Canyon Labs Acquires iuvo BioScience's Lab Services and Scientific Consulting Divisions
January 7, 2025
Canyon Labs has acquired the laboratory services and scientific consulting businesses of iuvo BioScience, integrating the lab and consulting personnel into Canyon Labs' operations while iuvo retains its ophthalmic clinical research team. The deal expands Canyon Labs' testing and consulting capabilities (adding a Rochester, NY site) and allows iuvo to sharpen its focus on ophthalmic clinical trial services.
- Buyers
- Canyon Labs
- Targets
- iuvo BioScience
- Sellers
- iuvo BioScience
- Industry
- Healthcare Services
- Location
- New York, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Ampersand Capital Partners Invests in iuvo BioScience
September 28, 2022
Healthcare Services
Ampersand Capital Partners has agreed to acquire a stake in iuvo BioScience, a Rochester-based specialty CRO that provides laboratory, preclinical, clinical development, and scientific consulting services. The investment will fund expansion of iuvo's integrated service portfolio and laboratory capacity and support an active inorganic (add-on) growth strategy; founders Ben Burton and Mary Richardson will remain in leadership roles and as shareholders.
-
MedVenture Health Acquires Canyon Labs
May 19, 2023
Healthcare Services
MedVenture Health, a Salt Lake City-based private investment firm focused on medical devices and life sciences, has acquired Canyon Labs, an FDA-approved regulatory and laboratory testing services provider. The acquisition adds regulatory testing, analytical and microbiological capabilities (in a 17,000-sf facility) to MedVenture's portfolio to support its companies and accelerate product development and compliance.
-
iuvo BioScience Acquires Promedica International
January 18, 2024
Healthcare Services
iuvo BioScience, a Rochester-based specialty preclinical and clinical services provider backed by Ampersand Capital Partners, has acquired Promedica International, an ophthalmology-focused clinical CRO headquartered in Costa Mesa, California. The deal combines iuvo's laboratory and consulting capabilities with Promedica's ophthalmic clinical trial expertise to create an integrated end-to-end ophthalmology clinical research offering.
-
Verdesian Life Sciences Acquires Cytozyme Laboratories
April 27, 2021
Agriculture
Verdesian Life Sciences has acquired Cytozyme Laboratories, Inc.; Cascadia Capital served as exclusive financial advisor to Cytozyme. The acquisition brings together complementary biological and nutritional crop technologies to expand Verdesian's product portfolio and support sustainable yield solutions for growers.
-
Innovative Lab Services Acquires Overbrook Scientific
November 20, 2025
Healthcare Services
Innovative Lab Services (ILS) has acquired Overbrook Scientific, a provider of laboratory relocations, asset management, and multi-vendor instrument maintenance, to expand ILS's national footprint and specialized lifecycle capabilities. Overbrook's founder Ted Palashis and the full Overbrook team will join ILS and continue to lead laboratory lifecycle and technical services within the combined organization.
-
Curative Inc. Acquires KorvaLabs, Inc.
May 19, 2020
Healthcare Services
Curative Inc. has acquired KorvaLabs, a CLIA-certified and DEA-licensed analytical laboratory based in San Dimas, California, formalizing a partnership that supported Curative's manufacture and processing of its oral fluid COVID-19 test. The acquisition strengthens Curative's testing capacity — to date the organizations processed 245,371 tests together and were processing roughly 14,000 tests per day — and secures in-house manufacturing and processing capabilities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.